HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: Where do we stand?

Biochemical Society Transactions

Volumn 42, Issue 2, 2014, Pages 569-581

  Whittle, Nigel ^a   Singewald, Nicolas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anxiolytic therapy; Cognitive enhancer; Epigenetics; Histone acetyltransferase activator (HAT activator); Histone deacetylase inhibitor (HDAC inhibitor); Lysine acetylation; Trauma

Indexed keywords

BUTYRIC ACID; ENTINOSTAT; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT; NOOTROPIC AGENT;

ANXIETY DISORDER; BONE MARROW SUPPRESSION; COGNITIVE DEFECT; COGNITIVE THERAPY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; FEAR; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; LEARNING DISORDER; MENTAL DISEASE; MOLECULAR MECHANICS; NONHUMAN; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTRAUMA; QT PROLONGATION; RELAPSE; REVIEW; ANXIETY; DRUG EFFECTS; WOUNDS AND INJURIES;

ANXIETY; FEAR; HISTONE DEACETYLASE INHIBITORS; HUMANS; NOOTROPIC AGENTS; WOUNDS AND INJURIES;

EID: 84896976354     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130233     Document Type: Review

References (105)

1. Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R. and Walters, E.E. (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617-627 (Pubitemid 40973437)
2. Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H.U. and Jonsson, B. (2012) The economic cost of brain disorders in Europe. Eur. J. Neurol. 19, 155-162
3. Slade, T., Johnston, A., Oakley Browne, M.A., Andrews, G. and Whiteford, H. (2009) 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust. N.Z. J. Psychiatry 43, 594-605
4. Pull, C.B. (2007) Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders. Curr. Opin. Psychiatry 20, 30-35
5. Doehrmann, O., Ghosh, S.S., Polli, F.E., Reynolds, G.O., Horn, F., Keshavan, A., Triantafyllou, C., Saygin, Z.M., Whitfield-Gabrieli, S., Hofmann, S.G. et al. (2013) Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. JAMA Psychiatry 70, 87-97
6. Chapman, C., Mills, K., Slade, T., McFarlane, A.C., Bryant, R.A., Creamer, M., Silove, D. and Teesson, M. (2012) Remission from post-traumatic stress disorder in the general population. Psychol. Med. 42, 1695-1703
7. Otto, M.W., Smits, J.A.J. and Reese, H.E. (2005) Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin. Psychol. Sci. Pract. 12, 72-86 (Pubitemid 40309355)
8. Milad, M.R. and Quirk, G.J. (2012) Fear extinction as a model for translational neuroscience: ten years of progress. Annu. Rev. Psychol. 63, 129-151
9. Pape, H.C. and Pare, D. (2010) Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol. Rev. 90, 419-463
10. Orsini, C.A. and Maren, S. (2012) Neural and cellular mechanisms of fear and extinction memory formation. Neurosci. Biobehav. Rev. 36, 1773-1802
11. Myers, K.M., Carlezon, Jr, W.A. and Davis, M. (2011) Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 36, 274-293
12. Graham, B.M., Langton, J.M. and Richardson, R. (2010) Pharmacological enhancement of fear reduction: preclinical models. Br. J. Pharmacol. 164, 1230-1247
13. Smits, J.A., Rosenfield, D., Otto, M.W., Powers, M.B., Hofmann, S.G., Telch, M.J., Pollack, M.H. and Tart, C.D. (2013) D-Cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol. Psychiatry 73, 1054-1058
14. Hofmann, S.G., Smits, J.A., Rosenfield, D., Simon, N., Otto, M.W., Meuret, A.E., Marques, L., Fang, A., Tart, C. and Pollack, M.H. (2013) D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am. J. Psychiatry 170, 751-758
15. Litz, B.T., Salters-Pedneault, K., Steenkamp, M.M., Hermos, J.A., Bryant, R.A. and Otto, M.W. (2012) A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J. Psychiatr. Res. 46, 1184-11909
16. Whittle, N., Schmuckermair, C., Gunduz Cinar, O., Hauschild, M., Ferraguti, F., Holmes, A. and Singewald, N. (2013) Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology 64, 414-423
17. Hefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R.M., Saksida, L.M., Bussey, T.J., Singewald, N. and Holmes, A. (2008) Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J. Neurosci. 28, 8074-8085
18. Dunlop, B.W., Mansson, E. and Gerardi, M. (2012) Pharmacological innovations for posttraumatic stress disorder and medication-enhanced psychotherapy. Curr. Pharm. Des. 18, 5645-5658
19. Hofmann, S.G. (2007) Enhancing exposure-based therapy from a translational research perspective. Behav. Res. Ther. 45, 1987-2001
20. Gunduz-Cinar, O., Macpherson, K.P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T.S., Gorka, A.X., Alapafuja, S.O. et al. (2012) Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol. Psychiatry 18, 813-823
21. Haaker, J., Gaburro, S., Sah, A., Gartmann, N., Lonsdorf, T.B., Meier, K., Singewald, N., Pape, H.C., Morellini, F. and Kalisch, R. (2013) Single dose of L-dopa makes extinction memories context-independent and prevents the return of fear. Proc. Natl. Acad. Sci. U.S.A. 110, E2428-E2436
22. Zovkic, I.B. and Sweatt, J.D. (2013) Epigenetic mechanisms in learned fear: implications for PTSD. Neuropsychopharmacology 38, 77-93
23. Stefanko, D.P., Barrett, R.M., Ly, A.R., Reolon, G.K. and Wood, M.A. (2009) Modulation of long-term memory for object recognition via HDAC inhibition. Proc. Natl. Acad. Sci. U.S.A. 106, 9447-9452
24. Stafford, J.M. and Lattal, K.M. (2011) Is an epigenetic switch the key to persistent extinction? Neurobiol. Learn. Mem. 96, 35-40
25. Milad, M.R., Rauch, S.L., Pitman, R.K. and Quirk, G.J. (2006) Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol. Psychol. 73, 61-71
26. Quirk, G.J., Garcia, R. and Gonzalez-Lima, F. (2006) Prefrontal mechanisms in extinction of conditioned fear. Biol. Psychiatry 60, 337-343 (Pubitemid 44215848)
27. Myers, K.M. and Davis, M. (2002) Behavioral and neural analysis of extinction. Neuron 36, 567-584 (Pubitemid 35346753)
28. Schiller, D., Cain, C.K., Curley, N.G., Schwartz, J.S., Stern, S.A., Ledoux, J.E. and Phelps, E.A. (2008) Evidence for recovery of fear following immediate extinction in rats and humans. Learn. Mem. 15, 394-402 (Pubitemid 351786970)
29. Rowe, M.K. and Craske, M.G. (1998) Effects of varied-stimulus exposure training on fear reduction and return of fear. Behav. Res. Ther. 36, 719-734 (Pubitemid 28339791)
30. Rowe, M.K. and Craske, M.G. (1998) Effects of an expanding-spaced vs massed exposure schedule on fear reduction and return of fear. Behav. Res. Ther. 36, 701-717 (Pubitemid 28339790)
31. Effting, M. and Kindt, M. (2007) Contextual control of human fear associations in a renewal paradigm. Behav. Res. Ther. 45, 2002-2018 (Pubitemid 47210949)
32. Holmes, A. and Singewald, N. (2013) Individual differences in recovery from traumatic fear. Trends Neurosci. 36, 23-31
33. Alberini, C.M. (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol. Rev. 89, 121-145
34. McGaugh, J.L. (2000) Memory: a century of consolidation. Science 287, 248-251
35. Fischer, A., Sananbenesi, F., Mungenast, A. and Tsai, L.H. (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci. 31, 605-617
36. Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F. and Richmond, T.J. (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260 (Pubitemid 27406632)
37. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science 293, 1074-1080 (Pubitemid 32758077)
38. Delcuve, G.P., Khan, D.H. and Davie, J.R. (2012) Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin. Epigenetics 4, 5
39. Graff, J. and Tsai, L.H. (2013) The potential of HDAC inhibitors as cognitive enhancers. Annu. Rev. Pharmacol. Toxicol. 53, 311-330
40. Hayakawa, T. and Nakayama, J. (2011) Physiological roles of class I HDAC complex and histone demethylase. J. Biomed. Biotechnol. 2011, 129383
41. Guan, J.S., Haggarty, S.J., Giacometti, E., Dannenberg, J.H., Joseph, N., Gao, J., Nieland, T.J., Zhou, Y., Wang, X., Mazitschek, R. et al. (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60
42. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S. and van Kuilenburg, A.B. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749 (Pubitemid 36399066)
43. Bousiges, O., Neidl, R., Majchrzak, M., Muller, M.A., Barbelivien, A., Pereira de Vasconcelos, A., Schneider, A., Loeffler, J.P., Cassel, J.C. and Boutillier, A.L. (2013) Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning. PLoS ONE 8, e57816
44. Dagnas, M. and Mons, N. (2013) Region- and age-specific patterns of histone acetylation related to spatial and cued learning in the water maze. Hippocampus 23, 581-591
45. Bredy, T.W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y.E. and Barad, M. (2007) Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn. Mem. 14, 268-276 (Pubitemid 46625629)
46. Wei, W., Coelho, C.M., Li, X., Marek, R., Yan, S., Anderson, S., Meyers, D., Mukherjee, C., Sbardella, G., Castellano, S. et al. (2012) p300/CBP-associated factor selectively regulates the extinction of conditioned fear. J. Neurosci. 32, 11930-11941
47. Wang, W.S., Kang, S., Liu, W.T., Li, M., Liu, Y., Yu, C., Chen, J., Chi, Z.Q., He, L. and Liu, J.G. (2012) Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex. J. Neurosci. 32, 13763-13775
48. Malvaez, M., Sanchis-Segura, C., Vo, D., Lattal, K.M. and Wood, M.A. (2010) Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol. Psychiatry 67, 36-43
49. Chatterjee, S., Mizar, P., Cassel, R., Neidl, R., Selvi, B.R., Mohankrishna, D.V., Vedamurthy, B.M., Schneider, A., Bousiges, O., Mathis, C. et al. (2013) A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J. Neurosci. 33, 10698-10712
50. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V. and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
51. Fujita, Y., Morinobu, S., Takei, S., Fuchikami, M., Matsumoto, T., Yamamoto, S. and Yamawaki, S. (2012) Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal NR2B-containing NMDA receptor gene. J. Psychiatr. Res. 46, 635-643
52. Bredy, T.W. and Barad, M. (2008) The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. Learn. Mem. 15, 39-45 (Pubitemid 351171604)
53. Stafford, J.M., Raybuck, J.D., Ryabinin, A.E. and Lattal, K.M. (2012) Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction. Biol. Psychiatry 72, 25-33
54. Milad, M.R., Pitman, R.K., Ellis, C.B., Gold, A.L., Shin, L.M., Lasko, N.B., Zeidan, M.A., Handwerger, K., Orr, S.P. and Rauch, S.L. (2009) Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol. Psychiatry 66, 1075-1082
55. Camp, M., Norcross, M., Whittle, N., Feyder, M., D'Hanis, W., Yilmazer-Hanke, D., Singewald, N. and Holmes, A. (2009) Impaired Pavlovian fear extinction is a common phenotype across genetic lineages of the 129 inbred mouse strain. Genes Brain Behav. 8, 744-752
56. Whittle, N., Hauschild, M., Lubec, G., Holmes, A. and Singewald, N. (2010) Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J. Neurosci. 30, 13586-13596
57. Matsumoto, Y., Morinobu, S., Yamamoto, S., Matsumoto, T., Takei, S., Fujita, Y. and Yamawaki, S. (2013) Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder. Psychopharmacology 229, 51-62
58. Yamamoto, S., Morinobu, S., Fuchikami, M., Kurata, A., Kozuru, T. and Yamawaki, S. (2008) Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 33, 2108-2116 (Pubitemid 351992081)
59. Kuriyama, K., Honma, M., Soshi, T., Fujii, T. and Kim, Y. (2011) Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial. Psychopharmacology 218, 589-597
60. Kuriyama, K., Honma, M., Yoshiike, T. and Kim, Y. (2013) Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans. Neuropharmacology 64, 424-431
61. Peterson, G.M. and Naunton, M. (2005) Valproate: a simple chemical with so much to offer. J. Clin. Pharm. Ther. 30, 417-421 (Pubitemid 41603013)
62. Mimaki, T., Yabuuchi, H., Laird, H. and Yamamura, H.I. (1984) Effects of seizures and antiepileptic drugs on benzodiazepine receptors in rat brain. Pediatr. Pharmacol. 4, 205-211 (Pubitemid 15181776)
63. Miller, L.G., Greenblatt, D.J., Barnhill, J.G., Summer, W.R. and Shader, R.I. (1988) 'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA. Eur. J. Pharmacol. 148, 123-130 (Pubitemid 18082025)
64. Kramer, O.H., Zhu, P., Ostendorff, H.P., Golebiewski, M., Tiefenbach, J., Peters, M.A., Brill, B., Groner, B., Bach, I., Heinzel, T. and Gottlicher, M. (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 22, 3411-3420 (Pubitemid 36834871)
65. Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S.C., Carey, N. et al. (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J. 409, 581-589 (Pubitemid 351184977)
66. Bantscheff, M., Hopf, C., Savitski, M.M., Dittmann, A., Grandi, P., Michon, A.M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G. et al. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255-265
67. Harris, J.A. and Westbrook, R.F. (1998) Evidence that GABA transmission mediates context-specific extinction of learned fear. Psychopharmacology 140, 105-115 (Pubitemid 28524314)
68. Chhatwal, J.P., Myers, K.M., Ressler, K.J. and Davis, M. (2005) Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J. Neurosci. 25, 502-506
69. Lin, H.C., Mao, S.C. and Gean, P.W. (2009) Block of γ-aminobutyric acid-A receptor insertion in the amygdala impairs extinction of conditioned fear. Biol. Psychiatry 66, 665-673
70. Dalton, G.L., Wu, D.C., Wang, Y.T., Floresco, S.B. and Phillips, A.G. (2012) NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear. Neuropharmacology 62, 797-806
71. Monti, B. (2013) Histone post-translational modifications to target memory-related diseases. Curr. Pharm. Des. 19, 5065-5075
72. Peleg, S., Sananbenesi, F., Zovoilis, A., Burkhardt, S., Bahari-Javan, S., Agis-Balboa, R.C., Cota, P., Wittnam, J.L., Gogol-Doering, A., Opitz, L. et al. (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753-756
73. Kazantsev, A.G. and Thompson, L.M. (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 7, 854-868
74. Morris, M.J. and Monteggia, L.M. (2013) Unique functional roles for class I and class II histone deacetylases in central nervous system development and function. Int. J. Dev. Neurosci. 31, 370-381
75. Haggarty, S.J. and Tsai, L.H. (2011) Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity. Neurobiol. Learn. Mem. 96, 41-52
76. Morris, M.J., Mahgoub, M., Na, E.S., Pranav, H. and Monteggia, L.M. (2013) Loss of histone deacetylase 2 improves working memory and accelerates extinction learning. J. Neurosci. 33, 6401-6411
77. Bahari-Javan, S., Maddalena, A., Kerimoglu, C., Wittnam, J., Held, T., Bahr, M., Burkhardt, S., Delalle, I., Kugler, S., Fischer, A. and Sananbenesi, F. (2012) HDAC1 regulates fear extinction in mice. J. Neurosci. 32, 5062-5073
78. Karpova, N.N., Pickenhagen, A., Lindholm, J., Tiraboschi, E., Kulesskaya, N., Agustsdottir, A., Antila, H., Popova, D., Akamine, Y., Sullivan, R. et al. (2011) Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 334, 1731-1734
79. Camp, M., MacPherson, K.P., Lederle, L., Graybeal, C., Gaburro, S., Debrouse, L.M., Ihne, J.L., Bravo, J.A., O'Connor, R.M., Ciocchi, S. et al. (2012) Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology 37, 1534-1547
80. Siegl, S., Flor, P.J. and Fendt, M. (2008) Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear. NeuroReport 19, 1147-1150
81. Fendt, M., Schmid, S., Thakker, D.R., Jacobson, L.H., Yamamoto, R., Mitsukawa, K., Maier, R., Natt, F., Husken, D., Kelly, P.H. et al. (2008) mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol. Psychiatry 13, 970-979
82. Yasuda, S., Liang, M.H., Marinova, Z., Yahyavi, A. and Chuang, D.M. (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry 14, 51-59
83. McQuown, S.C. and Wood, M.A. (2011) HDAC3 and the molecular brake pad hypothesis. Neurobiol. Learn. Mem. 96, 27-34
84. McQuown, S.C., Barrett, R.M., Matheos, D.P., Post, R.J., Rogge, G.A., Alenghat, T., Mullican, S.E., Jones, S., Rusche, J.R., Lazar, M.A. and Wood, M.A. (2011) HDAC3 is a critical negative regulator of long-term memory formation. J. Neurosci. 31, 764-774
85. Gao, J., Siddoway, B., Huang, Q. and Xia, H. (2009) Inactivation of CREB mediated gene transcription by HDAC8 bound protein phosphatase. Biochem. Biophys. Res. Commun. 379, 1-5
86. Kida, S., Josselyn, S.A., Pena de Ortiz, S., Kogan, J.H., Chevere, I., Masushige, S. and Silva, A.J. (2002) CREB required for the stability of new and reactivated fear memories. Nat. Neurosci. 5, 348-355 (Pubitemid 34279815)
87. Kim, M.S., Akhtar, M.W., Adachi, M., Mahgoub, M., Bassel-Duby, R., Kavalali, E.T., Olson, E.N. and Monteggia, L.M. (2012) An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J. Neurosci. 32, 10879-10886
88. Agis-Balboa, R.C., Pavelka, Z., Kerimoglu, C. and Fischer, A. (2013) Loss of HDAC5 impairs memory function: implications for Alzheimer's disease. J. Alzheimer's Dis. 33, 35-44
89. Salminen, A., Tapiola, T., Korhonen, P. and Suuronen, T. (1998) Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res. Mol. Brain Res. 61, 203-206 (Pubitemid 28511364)
90. Ververis, K., Hiong, A., Karagiannis, T.C. and Licciardi, P.V. (2013) Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents. Biologics 7, 47-60
91. Herry, C., Ferraguti, F., Singewald, N., Letzkus, J.J., Ehrlich, I. and Luthi, A. (2010) Neuronal circuits of fear extinction. Eur. J. Neurosci. 31, 599-612
92. Bramham, C.R. and Messaoudi, E. (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76, 99-125 (Pubitemid 41242884)
93. Peters, J., Dieppa-Perea, L.M., Melendez, L.M. and Quirk, G.J. (2010) Induction of fear extinction with hippocampal-infralimbic BDNF. Science 328, 1288-1290
94. Kirtley, A. and Thomas, K.L. (2010) The exclusive induction of extinction is gated by BDNF. Learn. Mem. 17, 612-619
95. Soliman, F., Glatt, C.E., Bath, K.G., Levita, L., Jones, R.M., Pattwell, S.S., Jing, D., Tottenham, N., Amso, D., Somerville, L.H. et al. (2010) A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327, 863-866
96. Halsall, J., Gupta, V., O'Neill, L.P., Turner, B.M. and Nightingale, K.P. (2012) Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. PLoS ONE 7, e33453
97. Castren, E. and Rantamaki, T. (2010) The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev. Neurobiol. 70, 289-297
98. Morris, M.J., Karra, A.S. and Monteggia, L.M. (2010) Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain. Behav. Pharmacol. 21, 409-419
99. Lattal, K.M., Barrett, R.M. and Wood, M.A. (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav. Neurosci. 121, 1125-1131 (Pubitemid 350051316)
100. Itzhak, Y., Anderson, K.L., Kelley, J.B. and Petkov, M. (2012) Histone acetylation rescues contextual fear conditioning in nNOS KO mice and accelerates extinction of cued fear conditioning in wild type mice. Neurobiol. Learn. Mem. 97, 409-417
101. Gurvich, N., Tsygankova, O.M., Meinkoth, J.L. and Klein, P.S. (2004) Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 64, 1079-1086 (Pubitemid 38176913)
102. Tabuchi, A., Nakaoka, R., Amano, K., Yukimine, M., Andoh, T., Kuraishi, Y. and Tsuda, M. (2000) Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels. J. Biol. Chem. 275, 17269-17275
103. Tapia-Arancibia, L., Aliaga, E., Silhol, M. and Arancibia, S. (2008) New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 59, 201-220
104. Baker-Andresen, D., Flavell, C.R., Li, X. and Bredy, T.W. (2013) Activation of BDNF signaling prevents the return of fear in female mice. Learn. Mem. 20, 237-240
105. Graff, J., Joseph, N.F., Horn, M.E., Sarniei, A., Meng, J., Seo, J., Rei, D., Bero, A.W., Phan, T.X., Wagner, F. et al. (2014) Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell 156, 261-276